Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-24-000065
Filing Date
2024-08-07
Accepted
2024-08-07 16:07:48
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20240630.htm   iXBRL 10-Q 593573
2 EX-10.4 ullmannemploymentagreement.htm EX-10.4 208947
3 EX-10.5 cntx-formofinducementgrant.htm EX-10.5 24636
4 EX-10.6 cntx-formofstockoptionagre.htm EX-10.6 20620
5 EX-31.1 cntx2024-063010xqexhibit311.htm EX-31.1 10763
6 EX-31.2 cntx2024063010-qexhibit312.htm EX-31.2 10765
7 EX-32.1 cntx2024063010-qexhibit321.htm EX-32.1 6570
  Complete submission text file 0001842952-24-000065.txt   3829760

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20240630.xsd EX-101.SCH 26557
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20240630_cal.xml EX-101.CAL 24335
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20240630_def.xml EX-101.DEF 96255
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20240630_lab.xml EX-101.LAB 417255
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20240630_pre.xml EX-101.PRE 269234
61 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20240630_htm.xml XML 329266
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 241183688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)